how should I integrate dietary modifications into a multimodal osteoarthritis management plan for dogs?

Question

Accepted Answer

Dietary modification is a first-line, evidence-supported component of multimodal osteoarthritis (OA) management in dogs, with omega-3 fatty acids carrying the strongest evidence base of all nutraceutical interventions. The 2022 AAHA Pain Management Guidelines concluded that omega-3 fatty acids are the only nutraceutical for which the strength of evidence rises above low across a comprehensive review of all supplements evaluated for canine OA.6 Omega-3 fatty acid supplementation produces objective, measurable improvements in weight-bearing. Dogs with OA fed a diet high in fish oil-derived omega-3 fatty acids for 90 days showed improvement in objective weight-bearing assessed by gait analysis.4 Long-chain omega-3 polyunsaturated fatty acids exert synovial anti-inflammatory effects in OA.12 In a standardized multimodal protocol for young dogs (9 months–4 years) with radiographically confirmed OA, omega-3 supplementation was initiated at 100 mg/kg/day and increased to 200 mg/kg/day, combined with grapiprant at the recommended daily dose and a graduated leash exercise program targeting 60 minutes daily; client-reported outcome measures improved significantly at every monthly time point over 4 months, and peak vertical force increased significantly from baseline.11 Therapeutic diets formulated for joint health incorporate omega-3 fatty acids, green-lipped mussel (GLM) extract, glucosamine, and chondroitin sulfate as their primary active ingredients. These ingredients have demonstrated anti-inflammatory and chondroprotective effects, with potential adverse effects limited to mild gastrointestinal signs such as diarrhea — a substantially more favorable safety profile than NSAIDs.1 The combination of chondroitin sulfate, glucosamine, and omega-3 fatty acids has been shown to improve joint status in working dogs assessed by subjective measures.1 Cats with OA fed a diet enriched with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), GLM extract, and glucosamine/chondroi